Azelby Robert 4
4 · ADC Therapeutics SA · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Azelby Robert
Director
Transactions
- Sale
Common Shares
2024-06-17$2.89/sh−6,995$20,216→ 53,005 total
Footnotes (1)
- [F1]Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.